• Diagnosis​ Info ​and​ ​General​ ​Questions

  Bluebird Bio Presents Data from LentiGlobin Gene Therapy Trial in SCD

  Posted by Sickle Cell Forum Administrator on June 24, 2020 at 10:43 am

  

  Bluebird Bio’s LentiGlobin safely prevents serious vaso-occlusive crises and acute chest syndrome in patients with SCD, Phase 1/2 trial results show. Read more here.

  What do you think of this news?

  Sickle Cell Forum Administrator replied 3 years, 10 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply